HSP90AA1 and breast carcinoma: Furthermore, this same strategy but with Geldanamycin, an antitumor antibiotic that inhibits Hsp90 function by binding to its ADP/ATP-binding pocket, successfully suppressed breast cancer stem cell population in mammospheres, along with proliferation and migration [97].